Successful Treatment of Central Retinal Artery Occlusion With Tissue Plasminogen Activator Followed by Recurrent Retinal Ischemia

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Purpose: To describe the use of intra-arterial tissue plasminogen activator (tPA) to treat central retinal artery occlusion (CRAO). Methods: A case and its findings were analyzed. Results: A 45-year-old man diagnosed with a CRAO and had cerebral angiography and treatment with intra-arterial tPA. After treatment, follow-up included optical coherence tomography (OCT), fundus photography, fluorescein angiography, and OCT angiography. The visual acuity (VA) improved from hand motions to 20/30 immediately after fibrinolysis. A vascular occlusion event the next day resulted in a decrease in VA to 20/400. After initiation of dual antiplatelet therapy, the patient’s VA improved to 20/20. As the retina recovered, the evolution of retinal ischemic changes to a finding similar to paracentral acute middle maculopathy was seen on imaging. Conclusions: This is the first report describing a patient safely started on dual antiplatelet therapy that led to vision improvement after initial treatment with intra-arterial tPA for a CRAO resulted in recurrent vision loss.

Original languageEnglish
Pages (from-to)622-626
Number of pages5
JournalJournal of VitreoRetinal Diseases
Volume8
Issue number5
DOIs
StatePublished - 1 Sep 2024

Keywords

  • central retinal artery occlusion (CRAO)
  • eye stroke
  • fibrinolysis
  • paracentral acute middle maculopathy (PAMM)
  • tissue plasminogen activator (tPA)

Fingerprint

Dive into the research topics of 'Successful Treatment of Central Retinal Artery Occlusion With Tissue Plasminogen Activator Followed by Recurrent Retinal Ischemia'. Together they form a unique fingerprint.

Cite this